Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.

Campbell DH, Lund ME, Nocon AL, Cozzi PJ, Frydenberg M, De Souza P, Schiller B, Beebe-Dimmer JL, Ruterbusch JJ, Walsh BJ.

PLoS One. 2018 Apr 19;13(4):e0196017. doi: 10.1371/journal.pone.0196017. eCollection 2018.

2.

Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling.

You J, Willcox M, Fitzgerald A, Schiller B, Cozzi PJ, Russell PJ, Walsh BJ, Wasinger VC, Graham PH, Li Y.

Anal Biochem. 2016 Mar 1;496:30-4. doi: 10.1016/j.ab.2015.12.006. Epub 2015 Dec 21.

PMID:
26717899
3.

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.

Chang L, Graham PH, Ni J, Hao J, Bucci J, Cozzi PJ, Li Y.

Crit Rev Oncol Hematol. 2015 Dec;96(3):507-17. doi: 10.1016/j.critrevonc.2015.07.005. Epub 2015 Jul 18. Review.

PMID:
26253360
4.

PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.

Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y.

Cell Death Dis. 2014 Oct 2;5:e1437. doi: 10.1038/cddis.2014.415.

5.

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.

Ni J, Cozzi PJ, Hao JL, Beretov J, Chang L, Duan W, Shigdar S, Delprado WJ, Graham PH, Bucci J, Kearsley JH, Li Y.

Prostate. 2014 May;74(6):602-17. doi: 10.1002/pros.22775. Epub 2014 Feb 12.

PMID:
24615685
6.

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.

Chang L, Graham PH, Hao J, Bucci J, Cozzi PJ, Kearsley JH, Li Y.

Cancer Metastasis Rev. 2014 Sep;33(2-3):469-96. doi: 10.1007/s10555-014-9493-5. Review.

PMID:
24445654
7.

Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.

Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y.

Cell Death Dis. 2013 Oct 24;4:e875. doi: 10.1038/cddis.2013.407.

8.

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.

Hao J, Madigan MC, Khatri A, Power CA, Hung TT, Beretov J, Chang L, Xiao W, Cozzi PJ, Graham PH, Kearsley JH, Li Y.

PLoS One. 2012;7(8):e40716. doi: 10.1371/journal.pone.0040716. Epub 2012 Aug 3.

9.

Role of the EpCAM (CD326) in prostate cancer metastasis and progression.

Ni J, Cozzi PJ, Duan W, Shigdar S, Graham PH, John KH, Li Y.

Cancer Metastasis Rev. 2012 Dec;31(3-4):779-91. doi: 10.1007/s10555-012-9389-1. Review.

PMID:
22718399
10.

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.

Hao J, Chen H, Madigan MC, Cozzi PJ, Beretov J, Xiao W, Delprado WJ, Russell PJ, Li Y.

Br J Cancer. 2010 Sep 28;103(7):1008-18. doi: 10.1038/sj.bjc.6605839. Epub 2010 Aug 24.

11.

Post-translation modification of proteins in tears.

You J, Fitzgerald A, Cozzi PJ, Zhao Z, Graham P, Russell PJ, Walsh BJ, Willcox M, Zhong L, Wasinger V, Li Y.

Electrophoresis. 2010 Jun;31(11):1853-61. doi: 10.1002/elps.200900755.

PMID:
20506419
12.

CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer.

Hao JL, Cozzi PJ, Khatri A, Power CA, Li Y.

Curr Cancer Drug Targets. 2010 May;10(3):287-306. Review.

PMID:
20370680
13.

Angiogenesis as a strategic target for prostate cancer therapy.

Li Y, Cozzi PJ.

Med Res Rev. 2010 Jan;30(1):23-66. doi: 10.1002/med.20161. Review.

PMID:
19536866
14.

Promising tumor-associated antigens for future prostate cancer therapy.

Li Y, Cozzi PJ, Russell PJ.

Med Res Rev. 2010 Jan;30(1):67-101. doi: 10.1002/med.20165. Review.

PMID:
19536865
15.

Inhibition of micrometastatic prostate cancer cell spread in animal models by 213Bilabeled multiple targeted alpha radioimmunoconjugates.

Li Y, Song E, Abbas Rizvi SM, Power CA, Beretov J, Raja C, Cozzi PJ, Morgenstern A, Apostolidis C, Allen BJ, Russell PJ.

Clin Cancer Res. 2009 Feb 1;15(3):865-75. doi: 10.1158/1078-0432.CCR-08-1203.

16.

The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.

Madigan MC, Kingsley EA, Cozzi PJ, Delprado WJ, Russell PJ, Li Y.

Cancer Immunol Immunother. 2008 Sep;57(9):1367-79. doi: 10.1007/s00262-008-0473-x. Epub 2008 Feb 14.

PMID:
18273614
17.

Targeting uPA/uPAR in prostate cancer.

Li Y, Cozzi PJ.

Cancer Treat Rev. 2007 Oct;33(6):521-7. Epub 2007 Jul 19. Review.

PMID:
17658220
18.

MUC1 is a promising therapeutic target for prostate cancer therapy.

Li Y, Cozzi PJ.

Curr Cancer Drug Targets. 2007 May;7(3):259-71. Review.

PMID:
17504123
19.

Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates.

Wang J, Abbas Rizvi SM, Madigan MC, Cozzi PJ, Power CA, Qu CF, Morgenstern A, Apostolidis C, Russell PJ, Allen BJ, Li Y.

Prostate. 2006 Dec 1;66(16):1753-67.

PMID:
16955401
20.

Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer.

Cozzi PJ, Wang J, Delprado W, Madigan MC, Fairy S, Russell PJ, Li Y.

Hum Pathol. 2006 Nov;37(11):1442-51. Epub 2006 Jul 26.

PMID:
16949925
21.

MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.

Cozzi PJ, Wang J, Delprado W, Perkins AC, Allen BJ, Russell PJ, Li Y.

Clin Exp Metastasis. 2005;22(7):565-73. Epub 2006 Feb 11.

PMID:
16475027
22.

Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted alpha-therapy with 213Bi-conjugates.

Li Y, Abbas Rizvi SM, Blair nee Brown JM, Cozzi PJ, Qu CF, Ow KT, Tam PN, Perkins AC, Russell PJ, Allen BJ.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):896-908.

PMID:
15465208
23.

Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer.

Russell PJ, Ow KT, Tam PN, Juarez J, Kingsley EA, Qu CF, Li Y, Cozzi PJ, Martiniello-Wilks R.

Cancer Immunol Immunother. 2004 Nov;53(11):995-1004. Epub 2004 Jul 28.

PMID:
15449043
24.

Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin alpha-conjugate.

Li Y, Cozzi PJ, Qu CF, Zhang DY, Abbas Rizvi SM, Raja C, Allen BJ.

Cancer Lett. 2004 Mar 18;205(2):161-71.

PMID:
15036648
25.

Simple technique for identifying the linea alba in lower abdominal incisions.

Bariol SV, Lambrakis P, Cozzi PJ.

ANZ J Surg. 2003 Aug;73(8):649.

PMID:
12887539
26.

Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses.

Cozzi PJ, Burke PB, Bhargav A, Heston WD, Huryk B, Scardino PT, Fong Y.

Prostate. 2002 Oct 1;53(2):95-100.

PMID:
12242723
27.

Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.

Cozzi PJ, Malhotra S, McAuliffe P, Kooby DA, Federoff HJ, Huryk B, Johnson P, Scardino PT, Heston WD, Fong Y.

FASEB J. 2001 May;15(7):1306-8. No abstract available.

PMID:
11344122
28.

On taking my mother's blood pressure

Cozzi PJ.

West J Med. 2000 Sep;173(3):215. No abstract available.

29.
30.

Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogs.

Cozzi PJ, Bajorin DF, Tong W, Nguyen H, Scott J, Heston WD, Dalbagni G.

Clin Cancer Res. 1999 Sep;5(9):2629-37.

31.
32.

Cryotherapy for neuroendocrine liver metastases.

Seifert JK, Cozzi PJ, Morris DL.

Semin Surg Oncol. 1998 Mar;14(2):175-83.

PMID:
9492888
33.

Renal cryotherapy in a sheep model; a feasibility study.

Cozzi PJ, Lynch WJ, Collins S, Vonthethoff L, Morris DL.

J Urol. 1997 Feb;157(2):710-2.

PMID:
8996403
34.

Cryosurgery.

Dwerryhouse SJ, Cozzi PJ, Morris DL.

Surg Technol Int. 1997;6:85-9.

PMID:
16160959
35.

In vitro and in vivo assessment of urethral warming catheters for the transperineal cryoablation of prostatic carcinoma.

Cozzi PJ, Lynch WJ, Robson N, Vonthethoff L, Lumley T, Morris DL.

Br J Urol. 1996 Oct;78(4):589-95.

PMID:
8944516
36.

Laparoscopic vs open ultrasound of the liver: an in vitro study.

Cozzi PJ, McCall JL, Jorgensen JO, Morris DL.

HPB Surg. 1996;10(2):87-9.

37.

Two cases of spontaneous liver rupture and literature review.

Cozzi PJ, Morris DL.

HPB Surg. 1996;9(4):257-60. Review.

38.

Critical temperature for in vivo cryoablation of human prostate cancer in a xenograft model.

Cozzi PJ, Lawson JA, Lynch WJ, Morris DL.

Br J Urol. 1996 Jan;77(1):89-92.

PMID:
8653323
39.

Bioactivity of recombinant feline interleukin-2 on human and feline leukocytes.

Cozzi PJ, Padrid P, Tompkins MB, Alegre ML, Takeda J, Leff AR.

Vet Immunol Immunopathol. 1995 Sep;48(1-2):27-33.

PMID:
8533314
40.

Pulmonary artery diastolic-occlusion pressure gradient is increased in acute pulmonary embolism.

Cozzi PJ, Hall JB, Schmidt GA.

Crit Care Med. 1995 Sep;23(9):1481-4.

PMID:
7664549
41.

Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors.

Cozzi PJ, Englund R, Morris DL.

Cancer. 1995 Aug 1;76(3):501-9.

PMID:
8625133
42.

Airway compression by a mediastinal mass.

Cozzi PJ, Schmidt GA.

Chest. 1994 Oct;106(4):1237-8. No abstract available.

PMID:
7924501
43.

Thrombocytopenia after hepatic cryotherapy for colorectal metastases: correlates with hepatocellular injury.

Cozzi PJ, Stewart GJ, Morris DL.

World J Surg. 1994 Sep-Oct;18(5):774-6; discussion 777.

PMID:
7975699
44.

Poem: burning out.

Cozzi PJ.

West J Med. 1994 May;160(5):439. No abstract available.

45.

Poems: wish.

Cozzi PJ.

West J Med. 1994 Apr;160(4):377. No abstract available.

46.

Sequence and functional characterization of feline interleukin 2.

Cozzi PJ, Padrid PA, Takeda J, Alegre ML, Yuhki N, Leff AR.

Biochem Biophys Res Commun. 1993 Aug 16;194(3):1038-43.

PMID:
8352761
47.

Ode.

Cozzi PJ.

J Gen Intern Med. 1993 Apr;8(4):224. doi: 10.1007/BF02599272. No abstract available.

PMID:
27519503
48.

Activation of tracheal smooth muscle responsiveness by fMLP-treated HL-60 cells and neutrophils.

Munoz NM, Hamann KJ, Vita A, Cozzi PJ, Baranowski S, Solway J, Leff AR.

Am J Physiol. 1993 Mar;264(3 Pt 1):L222-8.

PMID:
8460711
49.

Prayer of the junior author.

Cozzi PJ.

J Gen Intern Med. 1992 Jul;7(4):468. doi: 10.1007/BF02599173. No abstract available.

PMID:
27519348
50.

Ards.

Cozzi PJ.

J Gen Intern Med. 1992 Jul;7(4):410. doi: 10.1007/BF02599157. No abstract available.

PMID:
27519345

Supplemental Content

Loading ...
Support Center